Online Intervention for Gestational Diabetes Postpartum Care

(SUNRISE Trial)

Enrolling by invitation at 1 trial location
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of California, Davis
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve postpartum care for individuals who had gestational diabetes (GDM) during pregnancy. It tests an online program that provides helpful health information and uses techniques like motivational interviewing (a counseling approach) and personalized risk information to encourage participation in diabetes prevention activities after childbirth. The trial compares different combinations of these techniques to identify the most effective approach. It is ideal for those who experienced GDM, speak English, and are part of the Kaiser Permanente Northern California network. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance postpartum health care for many.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that the digital health program tested in this trial includes methods such as Action Planning, Motivational Interviewing, Tailored Risk Information, and Values Affirmation. Although specific safety data from past studies is lacking, these methods are generally safe and widely used in healthcare.

Action Planning, while lacking specific safety data, commonly helps patients manage conditions like gestational diabetes by setting clear goals and steps.

Motivational Interviewing is a well-known technique that boosts motivation to change behavior. Studies have found it effective and safe for helping women with gestational diabetes become more active.

Tailored Risk Information provides patients with personalized health details. Although specific safety data isn't available, this approach regularly helps patients understand their health risks and take preventive steps.

Values Affirmation involves reflecting on personal values to encourage positive changes, such as increased interest in preventing diabetes. Research shows it is practical and well-accepted in healthcare.

Overall, these methods are well-integrated into healthcare and considered safe. Participants can feel confident knowing these strategies have been used successfully and safely in similar settings.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative methods for managing postpartum care in gestational diabetes. Traditional treatments often focus on medication and dietary changes during pregnancy. This trial, however, examines how psychological and behavioral strategies like action planning, motivational interviewing, tailored risk information, and values affirmation can be integrated into online interventions. These approaches aim to empower mothers with personalized, actionable tools to maintain healthy habits after childbirth. By shifting the focus to mental and behavioral support, this trial could pave the way for more holistic postpartum care strategies, addressing both physical and mental health needs.

What evidence suggests that this trial's treatments could be effective for gestational diabetes postpartum care?

Research shows that certain strategies can help women who had gestational diabetes improve their health after giving birth. In this trial, researchers will assign participants to different treatment arms to evaluate these strategies. Action planning (AP), one of the strategies tested, helps participants reach weight goals and lower diabetes risk. Motivational interviewing (MI) encourages more physical activity and supports lifestyle changes, which are important for preventing diabetes. Tailored risk information (TRI) helps women understand their personal risk, motivating them to take preventive steps after pregnancy. Studies on values affirmation (VA) suggest it boosts interest in lifestyle programs, aiding in diabetes prevention. Together, these methods aim to overcome obstacles and encourage women to participate in diabetes prevention care after childbirth.56789

Who Is on the Research Team?

SD

Susan D Brown, PhD

Principal Investigator

University of California, Davis

Are You a Good Fit for This Trial?

This trial is for pregnant individuals aged 18 or older with gestational diabetes, who speak English and are in contact with the Kaiser Permanente Northern California's perinatal service. It excludes those currently hospitalized, with pregnancy loss, prior requests to avoid research invites, eating disorders, or pre-pregnancy diabetes.

Inclusion Criteria

You are currently pregnant and have gestational diabetes.
You have been in touch with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center.
Able to communicate in English

Exclusion Criteria

You were diagnosed with diabetes before getting pregnant.
The mother or baby is currently staying in the hospital.
You have a history of an eating disorder.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention

4-12 weeks
Online interaction

Follow-up

Participants are monitored for completion of recommended postpartum diabetes screening and uptake of lifestyle programs

4-52 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Action planning (AP)
  • Motivational Interviewing-based (MI)
  • Standard Health Information
  • Tailored Risk Information (TRI)
  • Values Affirmation (VA)
Trial Overview The study tests a digital health program designed to encourage postpartum screening and lifestyle changes for diabetes prevention. Participants receive standard health info plus up to four additional components like motivational interviewing and action planning using an interactive online platform.
How Is the Trial Designed?
16Treatment groups
Experimental Treatment
Group I: Condition 9Experimental Treatment4 Interventions
Group II: Condition 8Experimental Treatment2 Interventions
Group III: Condition 7Experimental Treatment3 Interventions
Group IV: Condition 6Experimental Treatment3 Interventions
Group V: Condition 5Experimental Treatment4 Interventions
Group VI: Condition 4Experimental Treatment3 Interventions
Group VII: Condition 3Experimental Treatment4 Interventions
Group VIII: Condition 2Experimental Treatment4 Interventions
Group IX: Condition 16Experimental Treatment1 Intervention
Group X: Condition 15Experimental Treatment2 Interventions
Group XI: Condition 14Experimental Treatment2 Interventions
Group XII: Condition 13Experimental Treatment3 Interventions
Group XIII: Condition 12Experimental Treatment2 Interventions
Group XIV: Condition 11Experimental Treatment3 Interventions
Group XV: Condition 10Experimental Treatment3 Interventions
Group XVI: Condition 1Experimental Treatment5 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials
958
Recruited
4,816,000+

Kaiser Foundation Research Institute

Collaborator

Trials
28
Recruited
21,300+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Published Research Related to This Trial

The study involved 59 women with recent gestational diabetes and aimed to evaluate a diabetes risk reduction intervention, which successfully improved dietary habits, including energy and fat intake.
Despite the positive changes in diet, the intervention did not lead to increased physical activity, and recruitment for the study was more difficult than anticipated.
Investigation of a lifestyle change strategy for high-risk women with a history of gestational diabetes.Smith, BJ., Cinnadaio, N., Cheung, NW., et al.[2022]
The STAR MAMA trial is testing a 20-week postpartum program based on the Diabetes Prevention Program (DPP) to help low-income minority women with prior gestational diabetes or high BMIs reduce their risk of developing diabetes, targeting 180 women in San Francisco and Sonoma Counties.
Preliminary results show high engagement among participants, with 86% responding to health coaching calls, indicating that community-based adaptations of the DPP can effectively support postpartum women in managing their health.
Linking High Risk Postpartum Women with a Technology Enabled Health Coaching Program to Reduce Diabetes Risk and Improve Wellbeing: Program Description, Case Studies, and Recommendations for Community Health Coaching Programs.Athavale, P., Thomas, M., Delgadillo-Duenas, AT., et al.[2021]
An 18-month quality improvement project involving 15 clinical practices aimed to enhance postpartum Type 2 diabetes screening rates in women with a history of gestational diabetes, resulting in 67% of women having a documented postpartum visit and 33% undergoing T2DM screening.
The project successfully improved the delivery of patient education on important topics like GDM screening and T2DM risk reduction, but highlighted ongoing challenges in communication between prenatal and postpartum care providers that hindered optimal care.
The Ohio Gestational Diabetes Postpartum Care Learning Collaborative: Development of a Quality Improvement Initiative to Improve Systems of Care for Women.Shellhaas, C., Conrey, E., Crane, D., et al.[2023]

Citations

A Pregnancy and Postpartum Lifestyle Intervention in ...A Pregnancy and Postpartum Lifestyle Intervention in Women With Gestational Diabetes Mellitus Reduces Diabetes Risk Factors: A feasibility randomized control ...
Co-Designing a postpartum diabetes prevention program ...Our findings support research development that aligns with a core outcome set for diabetes after pregnancy prevention interventions, correlates with current ...
Postnatal care after gestational diabetes – a systematic review ...Consistent and evidence based postnatal care is key to improving maternal long-term health. We therefore aimed to review and compare ...
Comprehensive management of gestational diabetes mellitusGestational Diabetes Mellitus (GDM) affects 14.0% of pregnancies globally, with a 35% post-pregnancy relapse and a 60% risk of Type 2 Diabetes ( ...
The Gestational Diabetes' Effects on Moms (GEM) Cluster ...On average, over the 12-month postpartum period, women in the intervention had significantly higher odds of meeting weight goals than women in usual care (odds ...
Optimizing Postpartum Care for the Patient with Gestational ...Gestational diabetes mellitus (GDM) poses well-established risks to both the mother and infant. As over 50% of women with GDM will develop type 2 diabetes ...
Gestational Diabetes and Postpartum Care - CDPH - CA.govVisit the Maternal Health Conditions at Delivery Data Dashboard to learn more about gestational diabetes data. Skip to main content If you are ​currently ...
15. Management of Diabetes in Pregnancy: Standards of Care ...It is recommended that generally healthy people do at least 150 min of moderate-intensity aerobic activity each week during pregnancy and ...
Online Intervention for Gestational Diabetes Postpartum ...Is the online intervention for gestational diabetes postpartum care safe for humans? The research articles reviewed do not provide specific safety data for the ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security